Results 181 to 190 of about 105,478 (251)

Shifting paradigm in locally advanced resectable gastric and gastroesophageal junction cancers. [PDF]

World J Gastrointest Oncol
Ismaili N.
europepmc   +1 more source

Immune Checkpoint Inhibitors and Immunomodulators for Cancer Immunotherapy: Insights Into Resistance and Therapeutic Strategies

Advanced Science, Volume 13, Issue 25, 4 May 2026.
The schematic diagram illustrates the roles of novel immune checkpoints, immunomodulatory factors, cell death and multimodal technologies in cancer immunotherapy. Abstract Cancer immunotherapy has redefined cancer treatment. However, the molecular and cellular basis of immune evasion and therapeutic resistance remains incompletely understood.
Fangquan Chen, Yang Yu, Xiutao Cai, Junhao Lin, Ruirui Liang, Rui Kang, Daolin Tang, Jiao Liu   +7 more
wiley   +1 more source

Long-term outcomes of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and its relevant risk factors in China: a retrospective study. [PDF]

Front Surg
Gao S, Zhang X, Yu Z, Zhang J.
europepmc   +1 more source

Loss of VMP1 Impairs Tight Junction Recycling and Aggravates Intestinal Barrier Dysfunction in Inflammatory Bowel Disease

Advanced Science, Volume 13, Issue 25, 4 May 2026.
This study identifies vacuole membrane protein 1 (VMP1) as a critical regulator of intestinal epithelial barrier homeostasis. VMP1 facilitates the recruitment of CORO1C to late endosomes, supporting Retromer‐mediated recycling of the tight junction protein Occludin.
Jiawei Zhao, Jianjun Zou, Chen Zhou, Yingui Wang, Yiman Liu, Yanqing Zhou, Yuxiang Wang, Xinyu Zhang, Huishu Yang, Hongjie Yin, Dongsheng Bai, Yue Zhao, Na Lu   +12 more
wiley   +1 more source

Folic acid-functionalized mesoporous silica nanoparticles integrating fluorouracil-derived carbon dots and porphyrin for targeted breast cancer chemo-photodynamic therapy. [PDF]

RSC Adv
Serag E, El-Fakharany EM, El-Maradny YA, El-Khouly ME.   +3 more
europepmc   +1 more source

Immune‐Related Polyradiculoneuropathy Associated With Immune Checkpoint Inhibitors: A Comprehensive Case Series

Brain and Behavior, Volume 16, Issue 5, May 2026.
ABSTRACT Objective Immune‐related polyradiculoneuropathy (irPRN) is a rare but potentially severe neurological adverse event secondary to immune checkpoint inhibitors (ICIs), closely resembling Guillain–Barré syndrome. This study aims to characterize the clinical presentation, neurophysiological findings, therapeutic strategies, and clinical outcomes ...
A. Llauradó, E. Lainez, H. Ariño, M. Gratacòs‐Viñola, J. L. Seoane, M. Roca‐Herrera, J. L. Restrepo‐Vera, D. Sanchez‐Tejerina, N. Raguer, R. Juntas‐Morales   +9 more
wiley   +1 more source

Drug induced hyperpigmentation: systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Alharithy R, Alotaibi K, Bin Salamah R, Altamimi R, Alqntash N, Alsarhan R, Khosyfan L, Alrowais S.   +7 more
europepmc   +1 more source

Macro Habitat‐Based T2‐Weighted MRI Radiomics and Deep Learning Fusion for Predicting Treatment Response and Prognosis After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Background Response to neoadjuvant chemoradiotherapy (NACRT) in locally advanced rectal cancer (LARC) is highly heterogeneous. Reliable pretreatment prediction of tumor regression and prognosis remains an unmet clinical need to optimize personalized management.
Xiaoli Jin, Jing Xu, Yeting Hu, Xin Chen, Suyun Li, Qichun Wei, Sebastian Dieter, Bohai Feng   +7 more
wiley   +1 more source

Complete Response with Modified FLOX in Metastatic Colon Cancer: A Case Report

Journal of Coloproctology
Denis Artico Galhera, Camila Motta Venchiarutti Moniz   +1 more
doaj   +1 more source

Impact of Germline <i>BRCA</i> Mutation Status on Antitumor Activity of Modified FOLFIRINOX in Patients With Advanced Pancreatic Cancer: An Exploratory Analysis. [PDF]

JCO Precis Oncol
Lee L, Tachibana Y, Matsuo S, Niina Y, Fujiyama T, Hisano T, Sugimoto R, Akashi T, Ogoshi K, Furukawa M.   +9 more
europepmc   +1 more source